| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2018 | Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapy | TUNG-HUNG SU ; Liao C.-H; CHEN-HUA LIU ; KAI-WEN HUANG ; Tseng T.-C; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Radiology | 9 | 10 | |
| 2008 | Acute fatty liver of pregnancy with concurrent acute hepatitis B virus infection | TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | American Journal of Gastroenterology | 0 | 0 | |
| 2022 | Acute-phase serum amyloid A for early detection of hepatocellular carcinoma in cirrhotic patients with low AFP level | Wu, Jin-Lin; TUNG-HUNG SU ; PEI-JER CHEN ; YUN-RU CHEN | Scientific reports | 3 | 2 | |
| 2015 | Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy | Liang C.-C.; CHEN-HUA LIU ; Chung C.-S; Lin C.-K; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 7 | 6 | |
| 2018 | Age and gender may be the key points in hyperglycemic patients with Helicobacter pylori infection combined colorectal adenoma | Kuo Y.-C.; Shih S.-C.; Yu L.-Y.; MING-SHIANG WU ; TUNG-HUNG SU ; CHUN-JEN LIU ; Hu K.-C. | Helicobacter | 1 | 0 | |
| 2020 | Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer | TUNG-HUNG SU ; Tseng T.-C; CHUN-JEN LIU ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | International Journal of Cancer | 3 | 3 | |
| 2019 | Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism | TUNG-HUNG SU ; HUNG-CHIH YANG ; Tseng T.-C; Chou S.-W; CHIN-HSIEN LIN ; CHEN-HUA LIU ; CHUN-JEN LIU ; CHI-LING CHEN ; JIA-HORNG KAO | Movement Disorders | 11 | 10 | |
| 2021 | APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients | JIA-HORNG KAO ; Jeng W.-J.; Ning Q.; TUNG-HUNG SU ; Tseng T.-C.; Ueno Y.; Yuen M.-F. | Hepatology International | 21 | 17 | |
| 2007 | APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: More questions than answers [5] | TUNG-HUNG SU ; JIA-HORNG KAO ; DING-SHINN CHEN | Hepatology | 0 | 0 | |
| 2021 | Artificial intelligence in precision medicine in hepatology | TUNG-HUNG SU ; CHIH-HORNG WU ; JIA-HORNG KAO | Journal of gastroenterology and hepatology | 19 | 15 | |
| 2016 | Associated factors and clinical implications of serum aminotransferase elevation in scrub typhus | TUNG-HUNG SU ; CHUN-JEN LIU ; Shu P.-Y.; Fu Y.-H.; Chang C.-H.; Jao P.; JIA-HORNG KAO | Journal of Microbiology, Immunology and Infection | 3 | 3 | |
| 2019 | Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Children With a Normal Alanine Aminotransferase Level | HO-SHENG CHEN ; JIA-FENG WU ; TUNG-HUNG SU ; HUEY-LING CHEN ; HONG-YUAN HSU ; Xia N.-S.; PEI-JER CHEN ; MEI-HWEI CHANG | Hepatology | 10 | 7 | |
| 2020 | Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy | Tseng T.-C.; Peng C.-Y; Hsu Y.-C; TUNG-HUNG SU ; Wang C.-C; CHUN-JEN LIU ; HUNG-CHIH YANG ; Yang W.-T; Lin C.-H; Yu M.-L; Lai H.-C; Tanaka Y; Nguyen M.H; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Liver Cancer | 12 | 11 | |
| 2018 | Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan | Hsieh M.-H.; Yeh M.-L.; TUNG-HUNG SU ; Liu T.-W.; Huang C.-F.; Huang C.-I.; Wang S.-C.; Huang J.-F.; Dai C.-Y.; JIA-HORNG KAO ; Chuang W.-L.; PEI-JER CHEN ; CHUN-JEN LIU ; Yu M.-L. | Journal of the Formosan Medical Association | 5 | 4 | |
| 2016 | Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model | Li Y.-T.; CHUN-JEN LIU ; TUNG-HUNG SU ; Cheng H.-R.; YUNG-MING JENG ; Lin H.-L.; Wang C.-C.; JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN ; Wu H.-L. | Oncotarget | 4 | 4 | |
| 2019 | Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma | TUNG-HUNG SU ; CHUN-JEN LIU ; Tseng T.-C; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 23 | 23 | |
| 2021 | Clinical and histologic features of patients with biopsy-proven metabolic dysfunction-associated fatty liver disease | Huang S.-C.; Su H.-J; JIA-HORNG KAO ; Tseng T.-C; HUNG-CHIH YANG ; TUNG-HUNG SU ; PEI-JER CHEN ; CHUN-JEN LIU | Gut and Liver | 23 | 23 | |
| 2014 | Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously | Cheng H.-R.; JIA-HORNG KAO ; Wu H.-L.; Chen T.-C.; Tseng T.-C.; CHEN-HUA LIU ; TUNG-HUNG SU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU | Liver International | 12 | 11 | |
| 2020 | The clinical manifestations and management of COVID-19-related liver injury | TUNG-HUNG SU ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 26 | 22 | |
| 2019 | Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma | SIH-HAN LIAO ; TUNG-HUNG SU ; YUNG-MING JENG ; PO-CHIN LIANG ; DING-SHINN CHEN ; CHIEN-HUNG CHEN ; JIA-HORNG KAO | Hepatology | 38 | 42 |
